Clinical trial
Evaluation of Safety and Efficacy of VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following High-Dose Melphalan Treatment and Autologous PBSCT (Minimal Residual Disease, Partial Remission or Stable Disease)
NCT00311337 is registered in ClinicalTrials.gov with University of Wuerzburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Safety and Efficacy of VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following High-Dose Melphalan Treatment and Autologous PBSCT (Minimal Residual Disease, Partial Remission or Stable Disease)
- Lead sponsor
- University of Wuerzburg
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- October 31, 2005
- Completion date
- October 31, 2010
- Enrollment
- 61
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.